These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 24772891)
1. [Characterization of BZLF1 gene and its promoter Zp of EBV strains in children with EBV-associated diseases in recent 5 years in Beijing area]. Liu YL; Ai UH; Yan J; Guan XL; Liu CY; Xie ZD Bing Du Xue Bao; 2014 Jan; 30(1):6-12. PubMed ID: 24772891 [TBL] [Abstract][Full Text] [Related]
2. Characterization of Epstein-Barr virus (EBV) BZLF1 gene promoter variants and comparison of cellular gene expression profiles in Japanese patients with infectious mononucleosis, chronic active EBV infection, and EBV-associated hemophagocytic lymphohistiocytosis. Imajoh M; Hashida Y; Murakami M; Maeda A; Sato T; Fujieda M; Wakiguchi H; Daibata M J Med Virol; 2012 Jun; 84(6):940-6. PubMed ID: 22511310 [TBL] [Abstract][Full Text] [Related]
3. Characterization of variants in the promoter of BZLF1 gene of EBV in nonmalignant EBV-associated diseases in Chinese children. Jin Y; Xie Z; Lu G; Yang S; Shen K Virol J; 2010 May; 7():92. PubMed ID: 20459737 [TBL] [Abstract][Full Text] [Related]
6. Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas. Martini M; Capello D; Serraino D; Navarra A; Pierconti F; Cenci T; Gaidano G; Larocca LM J Infect; 2007 Mar; 54(3):298-306. PubMed ID: 16784778 [TBL] [Abstract][Full Text] [Related]
8. Identification of ARKL1 as a Negative Regulator of Epstein-Barr Virus Reactivation. Siddiqi UZ; Vaidya AS; Li X; Marcon E; Tsao SW; Greenblatt J; Frappier L J Virol; 2019 Oct; 93(20):. PubMed ID: 31341047 [TBL] [Abstract][Full Text] [Related]
9. Regulation of the BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin-treated B cells. Daibata M; Speck SH; Mulder C; Sairenji T Virology; 1994 Feb; 198(2):446-54. PubMed ID: 8291228 [TBL] [Abstract][Full Text] [Related]
10. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome. Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005 [TBL] [Abstract][Full Text] [Related]
11. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus. Kraus RJ; Mirocha SJ; Stephany HM; Puchalski JR; Mertz JE J Virol; 2001 Jan; 75(2):867-77. PubMed ID: 11134300 [TBL] [Abstract][Full Text] [Related]
12. Identification of an epithelial cell differentiation responsive region within the BZLF1 promoter of the Epstein-Barr virus. Karimi L; Crawford DH; Speck S; Nicholson LJ J Gen Virol; 1995 Apr; 76 ( Pt 4)():759-65. PubMed ID: 9049321 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome. Le Roux F; Sergeant A; Corbo L J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788 [TBL] [Abstract][Full Text] [Related]
14. Epidemiologic features of children with Epstein-Barr virus associated diseases in Hangzhou, China. Shi J; Ma W; Li W J Med Virol; 2020 Aug; 92(8):1277-1282. PubMed ID: 31750545 [TBL] [Abstract][Full Text] [Related]
15. Sequence variation of Epstein-Barr virus (EBV) BZLF1 gene in EBV-associated gastric carcinomas and nasopharyngeal carcinomas in Northern China. Luo B; Tang X; Jia Y; Wang Y; Chao Y; Zhao C Microbes Infect; 2011 Aug; 13(8-9):776-82. PubMed ID: 21527354 [TBL] [Abstract][Full Text] [Related]
16. Analysis of EBNA-1 and LMP-1 variants in diseases associated with EBV infection in Chinese children. Ai J; Xie Z; Liu C; Huang Z; Xu J Virol J; 2012 Jan; 9():13. PubMed ID: 22236445 [TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus BZLF1 gene polymorphisms: malignancy related or geographically distributed variants? Lorenzetti MA; Gantuz M; Altcheh J; De Matteo E; Chabay PA; Preciado MV Clin Microbiol Infect; 2014 Nov; 20(11):O861-9. PubMed ID: 24666405 [TBL] [Abstract][Full Text] [Related]
18. Distinctive Epstein-Barr virus variants associated with benign and malignant pediatric pathologies: LMP1 sequence characterization and linkage with other viral gene polymorphisms. Lorenzetti MA; Gantuz M; Altcheh J; De Matteo E; Chabay PA; Preciado MV J Clin Microbiol; 2012 Mar; 50(3):609-18. PubMed ID: 22205789 [TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta-induced reactivation of Epstein-Barr virus involves multiple Smad-binding elements cooperatively activating expression of the latent-lytic switch BZLF1 gene. Iempridee T; Das S; Xu I; Mertz JE J Virol; 2011 Aug; 85(15):7836-48. PubMed ID: 21593157 [TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes. Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]